3-Chloro-N-(2,5-dioxopyrrolidin-3-yl)benzo[b]thiophene-2-carboxamide

ID: ALA4544710

Chembl Id: CHEMBL4544710

PubChem CID: 155553241

Max Phase: Preclinical

Molecular Formula: C13H9ClN2O3S

Molecular Weight: 308.75

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  O=C1CC(NC(=O)c2sc3ccccc3c2Cl)C(=O)N1

Standard InChI:  InChI=1S/C13H9ClN2O3S/c14-10-6-3-1-2-4-8(6)20-11(10)13(19)15-7-5-9(17)16-12(7)18/h1-4,7H,5H2,(H,15,19)(H,16,17,18)

Standard InChI Key:  DUHXPFVQMXLGOK-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4544710

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 308.75

Molecular Weight (Monoisotopic): 308.0022

AlogP: 1.70

#Rotatable Bonds: 2

Polar Surface Area: 75.27

Molecular Species: NEUTRAL

HBA: 4

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 9.34

CX Basic pKa: ┄

CX LogP: 1.47

CX LogD: 1.47

Aromatic Rings: 2

Heavy Atoms: 20

QED Weighted: 0.83

Np Likeness Score: -1.39

References

1. Heim C, Pliatsika D, Mousavizadeh F, Bär K, Hernandez Alvarez B, Giannis A, Hartmann MD..  (2019)  De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives.,  62  (14): [PMID:31251063] [10.1021/acs.jmedchem.9b00454]

Source

Source(1):

• Scientific Literature